UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 232

Sortiert nach

A Biocompatibility Study of Plasma Nanocoatings onto Cobalt Chromium L605 Alloy for Cardiovascular Stent Applications

Materials, 2022-08, Vol.15 (17), p.5968

2022

Volltextzugriff (PDF)

Vascular functions of the plasminogen activation system

Arteriosclerosis, thrombosis, and vascular biology, 2007-06, Vol.27 (6), p.1231

2007

Volltextzugriff (PDF)

Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation

Arteriosclerosis, thrombosis, and vascular biology, 2016-11, Vol.36 (11), p.2167

2016

Volltextzugriff (PDF)

Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis

International journal of molecular sciences, 2016-03, Vol.17 (3), p.316-316

2016

Volltextzugriff (PDF)

Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling

The Journal of biological chemistry, 2017-02, Vol.292 (6), p.2345-2358

2017

Volltextzugriff (PDF)

Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma

Molecular cancer, 2015-07, Vol.14 (1), p.140-140, Article 140

2015

Volltextzugriff (PDF)

Plasminogen Is a Critical Host Pathogenicity Factor for Group A Streptococcal Infection

Science (American Association for the Advancement of Science), 2004-08, Vol.305 (5688), p.1283-1286

2004

Volltextzugriff (PDF)

Antidote-mediated control of an anticoagulant aptamer in vivo

Nature biotechnology, 2004-11, Vol.22 (11), p.1423-1428

2004

Volltextzugriff (PDF)

Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall

Blood, 2005-01, Vol.105 (1), p.192-198

2005

Volltextzugriff (PDF)

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

Circulation (New York, N.Y.), 2003-08, Vol.108 (5), p.512-515

2003

Volltextzugriff (PDF)

CagA + Helicobacter pylori , Not CagA - Helicobacter pylori , Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation

Frontiers in cardiovascular medicine, 2022-03, Vol.9, p.881372-881372

2022

Volltextzugriff (PDF)

Linking inflammation and thrombosis:Role of C-reactive protein

World journal of cardiology, 2010-11, Vol.2 (11), p.365-369

Fay, William P

2010

Volltextzugriff (PDF)

Double Knockouts Reveal that Protein Tyrosine Phosphatase 1B Is a Physiological Target of Calpain-1 in Platelets

Molecular and Cellular Biology, 2007-09, Vol.27 (17), p.6038-6052

2007

Volltextzugriff (PDF)

Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis

Circulation (New York, N.Y.), 2003-05, Vol.107 (20), p.2601-2606

2003

Volltextzugriff (PDF)

Murine thrombosis models

Thrombosis and haemostasis, 2004-09, Vol.92 (3), p.486

2004

Volltextzugriff (PDF)

MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells

The Journal of experimental medicine, 2005-09, Vol.202 (5), p.663-671

2005

Volltextzugriff (PDF)

The association of Klippel-Trenaunay syndrome and abdominal aortic aneurysms

Journal of vascular surgery cases and innovative techniques, 2019-09, Vol.5 (3), p.343-344

2019

Volltextzugriff (PDF)

Homocysteine and thrombosis: guilt by association?

Blood, 2012-03, Vol.119 (13), p.2977-2978

Fay, William P.

2012

Volltextzugriff (PDF)

The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4

Journal of cellular physiology, 2016-05, Vol.231 (5), p.1130-1141

2016

Volltextzugriff (PDF)

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance

Circulation (New York, N.Y.), 1999-06, Vol.99 (23), p.3050-3055

1999

Volltextzugriff (PDF)

Elevated postischemic tissue injury and leukocyte-endothelial adhesive interactions in mice with global deficiency in caveolin-2: role of PAI-1

American journal of physiology. Heart and circulatory physiology, 2021-03, Vol.320 (3), p.H1185-H1198

2021

Volltextzugriff (PDF)

Plasminogen Activator Inhibitor 1, Fibrin, and the Vascular Response to Injury

Trends in cardiovascular medicine, 2004-07, Vol.14 (5), p.196-202

Fay, William P

2004

Volltextzugriff (PDF)

Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent

Cardiovascular drugs and therapy, 2024-06

2024

Volltextzugriff (PDF)

No Sweetie Pie: Newly Uncovered Role for PAI (Plasminogen Activator Inhibitor)-1 in Inflammatory Responses to Ischemia/Reperfusion

Arteriosclerosis, thrombosis, and vascular biology, 2018-04, Vol.38 (4), p.695

2018

Volltextzugriff (PDF)

Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice

Circulation (New York, N.Y.), 1998-03, Vol.97 (10), p.1002-1008

1998

Volltextzugriff (PDF)

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(192)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Biocompatibility Study of Plasma Nanocoatings onto Cobalt Chromium L605 Alloy for Cardiovascular Stent Applications

Vascular functions of the plasminogen activation system

Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation

Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis

Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling

Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma

Plasminogen Is a Critical Host Pathogenicity Factor for Group A Streptococcal Infection

Antidote-mediated control of an anticoagulant aptamer in vivo

Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

CagA + Helicobacter pylori , Not CagA - Helicobacter pylori , Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation

Linking inflammation and thrombosis:Role of C-reactive protein

Double Knockouts Reveal that Protein Tyrosine Phosphatase 1B Is a Physiological Target of Calpain-1 in Platelets

Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis

Murine thrombosis models

MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells

The association of Klippel-Trenaunay syndrome and abdominal aortic aneurysms

Homocysteine and thrombosis: guilt by association?

The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance

Elevated postischemic tissue injury and leukocyte-endothelial adhesive interactions in mice with global deficiency in caveolin-2: role of PAI-1

Plasminogen Activator Inhibitor 1, Fibrin, and the Vascular Response to Injury

Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent

No Sweetie Pie: Newly Uncovered Role for PAI (Plasminogen Activator Inhibitor)-1 in Inflammatory Responses to Ischemia/Reperfusion

Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice

Suchergebnisse filtern